Dandan Li

Title: Dandan Li: Innovator in Biomedicine

Introduction

Dandan Li is a prominent inventor based in Kunming, China. He has made significant contributions to the field of biomedicine, particularly in the development of vaccines and viral strains. With a total of 2 patents, his work is recognized for its potential impact on public health.

Latest Patents

Dandan Li's latest patents include the "Coxsackievirus A6 strain CVA6-KM-J33 and use thereof." This invention provides a Coxsackievirus A6 (CVA6) strain that is susceptible to KMB17 cells, achieving a relatively high titer. The strain exhibits strong virulence and high pathogenicity, making it a valuable candidate for CVA6 vaccine development. Additionally, it can be used for immunogenicity evaluation, enhancing the accuracy of vaccine assessments.

Another notable patent is the "Enterovirus multi-antigen epitope fusion protein, gene, vaccine, and preparation method thereof." This invention relates to vaccine preparation technologies and features a genetically engineered protein vaccine with improved specificity and safety. The preparation method results in fewer impure proteins, thus enhancing the effectiveness of the combined vaccine.

Career Highlights

Dandan Li has worked at the Chinese Academy of Medical Sciences and the Institute of Medical Biology, where he has contributed to various research projects. His expertise in biomedicine has positioned him as a key figure in vaccine development and viral research.

Collaborations

Throughout his career, Dandan Li has collaborated with notable colleagues, including Guorun Jiang and Li Yu. These partnerships have facilitated advancements in his research and innovations.

Conclusion

Dandan Li's contributions to biomedicine through his patents and research highlight his role as an influential inventor. His work in vaccine development and viral strain research continues to pave the way for advancements in public health.